Pharma Jonpi . / 1.1 / .
11 febrero 2021
Celltrion Develops Tailored Neutralising Antibody Cocktail Treatment with CT-P59 to Tackle COVID-19 Variant Spread Using Its Antibody Development Platform .
‹
›
Inicio
Ver versión web